ACA Enrollment Sees Record 12% Drop as Pandemic-Era Subsidies Expire

The era of record-breaking expansion for the Affordable Care Act marketplaces has hit a sharp reversal. After years of subsidized growth, millions of Americans who purchase their own health insurance coverage through the federal and state exchanges are facing a volatile new reality: pay significantly more for the same protection or join the ranks of the uninsured.

New federal data released on June 26, 2026, reveals a significant contraction in the individual insurance market. Total marketplace enrollment fell from 21.8 million people in February 2025 to 19.2 million in February 2026. This decline of approximately 2.6 million people, or 12%, represents the steepest single-year drop since the marketplaces first opened for business in 2014. The Affordable Care Act (ACA) exchanges were designed as government-regulated platforms where individuals and small businesses could shop for private health insurance, but their stability has long been tied to the level of federal financial support available to consumers.

For health economists and policy analysts, the data serves as a stark reminder of the price sensitivity inherent in the individual market. The primary catalyst for the exodus appears to be the expiration of the ACA’s enhanced premium tax credits. These expanded subsidies, originally enacted during the COVID-19 pandemic to bolster the social safety net, were instrumental in doubling marketplace enrollment between 2020 and 2024. However, with the sunsetting of these provisions at the end of 2025, the financial cushion that millions relied upon vanished.

The resulting sticker shock was profound. When the extra premium tax credits lapsed, the average subsidized enrollee’s cost to maintain their existing plan surged by approximately 114%. While many consumers attempted to mitigate these costs by migrating to “bronze” or “silver” plans with lower premiums and higher deductibles, the aggregate financial burden remained heavy. Average monthly premium payments still rose by 58%, while deductibles climbed by 37%—an average increase of more than US$1,000 per person.

This affordability crisis is reflected in the “effectuated” enrollment rate—the number of people who actually pay their premiums after selecting a plan. By February 2026, only 83% of those who selected a plan had followed through with payment to secure their health insurance coverage, a notable decline from 91% the previous year.

The Trump administration has offered an alternative narrative for the shrinking numbers, focusing on regulatory integrity rather than purely economic factors. A federal government brief issued in June 2026 suggests that the previous era of high subsidies may have incentivized aggressive or improper behavior by insurance brokers. The brief argues that when plans became essentially free for some consumers, it became easier to enroll individuals without their full consent or knowledge. According to the Centers for Medicare & Medicaid Services (CMS), the agency tasked with overseeing the ACA, officials canceled 250,000 unauthorized enrollments and identified 200,000 unauthorized plan switches during 2025.

While federal regulators emphasize fraud prevention, independent analysts maintain that the expiration of subsidies is the dominant driver. The data shows a clear correlation between price hikes and disenrollment, though both factors likely played a role in the final tally. Interestingly, the impact was not felt equally across the country. In states relying on HealthCare.gov, the federal enrollment portal, enrollment plummeted by an average of 18.7%. Conversely, in states that operate their own state-run marketplaces, the decline was much more modest, averaging 6.3%. These state-level discrepancies suggest that localized outreach, additional state-funded subsidies, and more robust consumer assistance tools may have provided a buffer against the federal subsidy cliff.

The outlook for the remainder of the year remains cautious. Health policy experts project that enrollment could continue to slide, potentially settling between 16.5 million and 17.5 million by the end of 2026. Looking ahead to 2027, the financial pressure on consumers shows no signs of abating. Insurers participating in the marketplaces are already requesting typical premium increases of 14% for the coming year. If approved by state regulators, this would mark the second consecutive year of double-digit premium growth.

Beyond the balance sheets, the decline in marketplace enrollment carries significant implications for public health and the broader economy. Decades of economic research, including the landmark Oregon Health Insurance Experiment, demonstrate that consistent coverage leads to better management of chronic conditions, reduced depression, and a near-total elimination of catastrophic medical debt. Studies of the ACA’s Medicaid expansions have even linked insurance coverage to a 9% reduction in mortality among older low-income adults, largely because insured patients are more likely to receive early-stage cancer diagnoses when tumors are still treatable.

The loss of insurance often triggers a phenomenon known as “churn”—the frequent cycling in and out of coverage. For the American healthcare system, churn is an expensive inefficiency. Even brief gaps in insurance can lead to a doubling of emergency department visits and hospitalizations for manageable conditions like diabetes or asthma. When patients lose access to primary care, they often delay treatment until a condition becomes an acute, high-cost emergency.

As the 2026 data continues to be analyzed, the central question for policymakers is whether the current decline is a temporary market correction or the beginning of a long-term trend of diminishing affordability. For now, the numbers tell a story of a market in retreat, where the disappearance of federal support has forced millions to weigh the cost of their health against the constraints of their household budgets.